Hepatitis B vaccination and first central nervous system demyelinating events: reanalysis of a case-control study using the self-controlled case series method.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Vaccine

• Publication date

  2007-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.VACCINE.2007.05.032PMID 17597263
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Semiparametric analysis of case series data

  2006cited by this paper
• Hepatitis B vaccination and multiple sclerosis: the jury is still out

  2006cited by this paper
• Tutorial in biostatistics: the self‐controlled case series method

  2006cited by this paper
• Is there information after death?. In Discussion of Farrington CP and Whitaker HJ "Semiparametric analysis of case series data"

  2006cited by this paper
• Recombinant hepatitis B vaccine and the risk of multiple sclerosis: A prospective study [2] (multiple letters)

  2005cited by this paper
• Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study.

  2005cited by this paper
• Recombinant hepatitis B vaccine and the risk of multiple sclerosis

  2004cited by this paper
• Idiopathic intracranial hypertension: The presence and morphology of sinovenous stenosis

  2004cited by this paper
• Exposure to tricyclic and selective serotonin reuptake inhibitor antidepressants and the risk of hip fracture.

  2003cited by this paper
• Vaccinations and risk of central nervous system demyelinating diseases in adults.

  2003cited by this paper
• Hepatitis B Vaccination and First Central Nervous System Demyelinating Event: A Case-Control Study

  2002influential reference
• Stata Statistical Software: Release 7.

  2001cited by this paper
• Hepatitis B vaccination and the risk of multiple sclerosis.

  2001cited by this paper
• Vaccinations and multiple sclerosis.

  2001cited by this paper
• Vaccinations and multiple sclerosis.

  2001cited by this paper
• Vaccinations and multiple sclerosis.

  2001cited by this paper
• Intussusception among infants given an oral rotavirus vaccine.

  2001cited by this paper
• Does influenza vaccination exacerbate asthma? Analysis of a large cohort of children with asthma. Vaccine Safety Datalink Team.

  2000cited by this paper
• [The first episode of central nervous system demyelinization and hepatitis B virus vaccination].

  2000cited by this paper
• No increase in demyelinating diseases after hepatitis B vaccination

  1999cited by this paper
• Does Influenza Vaccination Exacerbate Asthma?

  1998cited by this paper
• Relative incidence estimation from case series for vaccine safety evaluation.

  1995cited by this paper
• Relative incidence estimation from case series for vaccine safety evaluation.

  1995cited by this paper

• Self-controlled case series design in vaccine safety: a systematic review

  2021cites this paper
• Hepatitis B vaccination and central demyelination - History, description and observed/expected analyses of 624 cases reported to the French pharmacovigilance over a 20-year period.

  2019cites this paper
• Observational safety study of specific outcomes after trivalent cell culture seasonal influenza vaccination (Optaflu®) among adults in THIN database of electronic UK primary healthcare records

  2018cites this paper
• Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis.

  2018influential citation
• Autoimmune diseases after hepatitis B immunization in adults: Literature review and meta-analysis, with reference to 'autoimmune/autoinflammatory syndrome induced by adjuvants' (ASIA).

  2018cites this paper
• Do Vaccines Cause Multiple Sclerosis (MS)

  2018cites this paper
• HBV vaccine and risk of developing multiple sclerosis: a systematic review and meta-analysis

  2018cites this paper
• Central Demyelinating Diseases after Vaccination Against Hepatitis B Virus: A Disproportionality Analysis within the VAERS Database

  2018cites this paper
• The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) Guide on Methodological Standards in Pharmacoepidemiology (Revision 6)

  2017cites this paper
• Vaccination and autoimmunity: Influenza vaccination and association with multiple sclerosis

  2017cites this paper
• Vaccines and multiple sclerosis: a systematic review

  2017cites this paper
• Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?

  2017cites this paper
• Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?

  2017cites this paper
• Acute Disseminated Encephalomyelitis: Idiopathic, Post‐infectious, and Post‐vaccination

  2015cites this paper
• [Vaccination: The dangerous lies of an "anti-vaccine" petition].

  2015cites this paper
• Self-controlled designs to control confounding

  2015cites this paper
• Fractional polynomial adjustment for time‐varying covariates in a self‐controlled case series analysis

  2014cites this paper
• Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model.

  2014cites this paper
• Perceptions of personal belief vaccine exemption policy: a survey of Arizona vaccine providers.

  2014cites this paper
• The spectrum of post-vaccination inflammatory CNS demyelinating syndromes.

  2014cites this paper
• Preparing for a Safety Evaluation of Rotavirus Vaccine Using Health Services Data in Ontario: The Development of a Diagnostic Algorithm for Intussusception, an Estimation of Baseline Incidence and an Evaluation of Methods

  2014influential citation
• Smooth Risk Functions for Self-Controlled Case Series Models

  2014cites this paper
• A new self-controlled case series method for analyzing spontaneous reports of adverse events after vaccination.

  2013cites this paper
• The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) Guide on Methodological Standards in Pharmacoepidemiology (Revision 2)

  2013cites this paper
• Methodological Issues With the Risk of Relapse Study in Patients With Multiple Sclerosis After Yellow Fever Vaccination—Reply

  2012cites this paper
• The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP)

  2012cites this paper
• Within-person study designs had lower precision and greater susceptibility to bias because of trends in exposure than cohort and nested case-control designs.

  2012cites this paper
• When should case‐only designs be used for safety monitoring of medical products?

  2012cites this paper
• Vaccination against infection in patients with multiple sclerosis

  2012cites this paper
• Biologically plausible and evidence-based risk intervals in immunization safety research.

  2012cites this paper
• Increase in multiple sclerosis activity after assisted reproduction technology

  2012cites this paper
• The U.S. Food and Drug Administration's Mini‐Sentinel Program

  2012cites this paper
• Immunizations and risk of multiple sclerosis: systematic review and meta-analysis

  2011cites this paper
• The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) Guide on Methodological Standards in Pharmacoepidemiology

  2011cites this paper
• Yellow fever vaccination and increased relapse rate in travelers with multiple sclerosis.

  2011cites this paper
• Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice

  2011influential citation
• Vaccines Are Not Associated With Metabolic Events in Children With Urea Cycle Disorders

  2011cites this paper
• Preventive medicines: vaccination, prophylaxis of infectious diseases, disinfectants.

  2011cites this paper
• Environmental Factors and Multiple Sclerosis: A Systematic Review

  2010cites this paper
• [The case series method].

  2010cites this paper
• Ten cases of systemic lupus erythematosus related to hepatitis B vaccine

  2009cites this paper
• A risk-benefit analysis of vaccination.

  2009cites this paper
• Long term side effects due to vaccination and pharmacovigilance.

  2009cites this paper
• CNS demyelination and quadrivalent HPV vaccination

  2009cites this paper
• The methodology of self-controlled case series studies

  2009cites this paper
• Vaccination in patients with chronic rheumatic or autoimmune diseases.

  2008cites this paper
• [Central nervous system demyelinating events and hepatitis B vaccine: a new episode of the never ending French saga!].

  2008cites this paper
• vaccination contre l ’ hépatite B : un nouvel épisode de l ’ interminable saga française ! Central nervous system demyelinating events and hepatitis B vaccine : A new episode of the never ending French saga !

  2008cites this paper
• Vaccination in Patients with Chronic Rheumatic or Autoimmune Diseases

  2008cites this paper
• MINI‐SENTINEL METHODS DEVELOPMENT CASE‐BASED METHODS WORKGROUP REPORT

  year unknowncites this paper